“…Several PCR based techniques can detect single-base mutations present in a minority population of human tumor cells: allele-speci®c PCR (AS-PCR), which includes MASA, PASA, MS-PCR, MAMA or ARMS ampli®cation (Cha et al, 1992;Chehab and Kan, 1989;Hasegawa et al, 1995;Hayashi et al, 1994Hayashi et al, , 1995Kwok et al, 1990;Li et al, 1990;Lo et al, 1991;Mansfeld and Bos, 1992;Orita et al, 1989;Ruano and Kidd, 1989;Rust et al, 1993;Seyama et al, 1992;Tada et al, 1993;Wu et al, 1989) as well as by primer mediated RFLP (Chen and Viola, 1991;Di Giuseppe et al, 1994;Kahn et al, 1991;Levi et al, 1991;Mitsudomi et al, 1991) or electrophoretic mobilitybased methods (Chen and Thilly, 1994;Fodde and Losekoot, 1994;Khrapko et al, 1994). However, these ampli®cation methods are susceptible to false-positive signals due to mis-extension of the mutant-speci®c primer on wild-type target.…”